Supplier Risk Mitigation in a Medical Device Company
The client received an FDA warning letter which resulted in the halt of new product releases to market. One of the key areas of concern identified by the FDA was the organization’s lack of purchasing controls. The client needed to improve upon the quality and reliability of its supply. Tefen was engaged to employ process controls to hedge the direct materials supplier risk and assist with implementation throughout the organization. Tefen was engaged by the client to help with supplier risk mitigation strategy for their global procurement organization.
